Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide.
Poosti F, Soebadi MA, Crijns H, De Zutter A, Metzemaekers M, Berghmans N, Vanheule V, Albersen M, Opdenakker G, Van Damme J, Sprangers B, Proost P, Struyf S.
Poosti F, et al. Among authors: berghmans n.
Clin Transl Immunology. 2022 Feb 2;11(2):e1370. doi: 10.1002/cti2.1370. eCollection 2022.
Clin Transl Immunology. 2022.
PMID: 35140938
Free PMC article.